Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Crit Care Med. 2009 Jan;37(1):263–269. doi: 10.1097/CCM.0b013e3181931ed3

Figure 8.

Figure 8

Co-transfection of hPXR and pGL3-rCYP3A2 natural promoter treated by human IL6 in HepG2 cells showed suppression of PXR activation. HepG2 cells were cotransfected with 1.4kb natural promoter pGL3-rCYP3A2-Luc reporter and human PXR. Transfected cells were treated with indicated IL6 concentration and/or rifampicin 10mM for 24 h before luciferase assay. Results are shown as —fold induction over vehicle control, which are represented as mean ± standard deviation from hexaplicate assay.